Literature DB >> 23978593

Prospective screening in familial nonmedullary thyroid cancer.

Samira M Sadowski1, Mei He, Krisana Gesuwan, Neelam Gulati, Francesco Celi, Maria J Merino, Naris Nilubol, Electron Kebebew.   

Abstract

BACKGROUND: Approximately 8% of nonmedullary thyroid cancers are familial. The optimal age for screening in familial nonmedullary thyroid cancer (FNMTC) is unknown.
METHODS: Kindreds with FNMTC (2 or more first-degree relatives affected) were screened prospectively with thyroid ultrasonography.
RESULTS: Fifteen kindreds showed an overall prevalence of thyroid nodule(s) ≥5 mm of 44% at screening; 19% in the second generation, and 90% in the generation anterior to the index case. The youngest age of detection was 10 years for thyroid nodules and 18 years for thyroid cancer. Microcalcification of thyroid nodules at screening was associated with a greater risk of cancer (P < .05). Family members diagnosed with thyroid cancer by ultrasonographic screening were diagnosed at a younger age and had a lower rate of extra thyroidal invasion (P < .05).
CONCLUSION: In FNMTC, first-degree relatives 10 years or older, including the generation anterior to the index case, should have thyroid screening by ultrasonography, which may result in earlier diagnosis. Published by Mosby, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23978593      PMCID: PMC3857607          DOI: 10.1016/j.surg.2013.06.019

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  16 in total

1.  On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds.

Authors:  N David Charkes
Journal:  Thyroid       Date:  2006-02       Impact factor: 6.568

Review 2.  Familial nonmedullary thyroid carcinoma.

Authors:  Carl D Malchoff; Diana M Malchoff
Journal:  Cancer Control       Date:  2006-04       Impact factor: 3.302

3.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

Review 4.  Management of a solitary thyroid nodule.

Authors:  E L Mazzaferri
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

5.  Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series.

Authors:  O Alsanea; N Wada; K Ain; M Wong; K Taylor; P H Ituarte; P A Treseler; H U Weier; N Freimer; A E Siperstein; Q Y Duh; H Takami; O H Clark
Journal:  Surgery       Date:  2000-12       Impact factor: 3.982

6.  American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.

Authors:  Hossein Gharib; Enrico Papini; Roberto Valcavi; H Jack Baskin; Anna Crescenzi; Massimo E Dottorini; Daniel S Duick; Rinaldo Guglielmi; Carlos Robert Hamilton; Martha A Zeiger; Michele Zini
Journal:  Endocr Pract       Date:  2006 Jan-Feb       Impact factor: 3.443

7.  Ultrasonographic screening for thyroid cancer in siblings of patients with apparently sporadic papillary carcinoma.

Authors:  Pedro Weslley Rosario; Augusto Flávio Campos Mineiro Filho; Brenda Sá Senna Prates; Livia Cristina Oliveira Silva; Rafaela Xavier Lacerda; Maria Regina Calsolari
Journal:  Thyroid       Date:  2012-07-12       Impact factor: 6.568

Review 8.  Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging.

Authors:  G H Tan; H Gharib
Journal:  Ann Intern Med       Date:  1997-02-01       Impact factor: 25.391

9.  Detection of asymptomatic differentiated thyroid carcinoma by neck ultrasonographic screening for familial nonmedullary thyroid carcinoma.

Authors:  Shinya Uchino; Shiro Noguchi; Hiroyuki Yamashita; Tsukasa Murakami; Shin Watanabe; Takahiro Ogawa; Akiko Tsuno; Shigeru Shuto
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

10.  Familial risks for nonmedullary thyroid cancer.

Authors:  Kari Hemminki; Charis Eng; Bowang Chen
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

View more
  4 in total

1.  Familiar Papillary Thyroid Carcinoma in a Large Brazilian Family Is Not Associated with Succinate Dehydrogenase Defects.

Authors:  Elen Dias Accordi; Paraskevi Xekouki; Bruna Azevedo; Rodrigo Bertollo de Alexandre; Carla Frasson; Siliane Marie Gantzel; Georgios Z Papadakis; Anna Angelousi; Constantine A Stratakis; Vanessa Santos Sotomaior; Fabio R Faucz
Journal:  Eur Thyroid J       Date:  2016-03-10

Review 2.  An update on familial nonmedullary thyroid cancer.

Authors:  Sabrine A Ammar; Wilson M Alobuia; Electron Kebebew
Journal:  Endocrine       Date:  2020-03-11       Impact factor: 3.633

3.  Results of Screening in Familial Non-Medullary Thyroid Cancer.

Authors:  Joanna Klubo-Gwiezdzinska; Lily Yang; Roxanne Merkel; Dhaval Patel; Naris Nilubol; Maria J Merino; Monica Skarulis; Samira M Sadowski; Electron Kebebew
Journal:  Thyroid       Date:  2017-07-19       Impact factor: 6.568

4.  HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer.

Authors:  Alexia L Weeks; Scott G Wilson; Lynley Ward; Jack Goldblatt; Jennie Hui; John P Walsh
Journal:  BMC Med Genet       Date:  2016-08-17       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.